EPAR

European Public Assessment Report.

The European Public Assessment Report (EPAR) is a document produced by the European Medicines Agency (EMA) that provides information on the scientific assessment of a medicine, including its benefits and risks, as well as recommendations for its use. The EPAR is intended to provide healthcare professionals and patients with transparent and accessible information about medicines authorized for use in the European Union (EU). The EPAR is produced for every medicine that is authorized through the centralized procedure in the EU, which is a regulatory process overseen by the EMA that allows a medicine to be authorized for use in all EU member states based on a single application. The EPAR includes information on the active substance(s) in the medicine, its pharmacological properties, clinical trial data, and information on its safety and effectiveness.

The EPAR is intended to help healthcare professionals make informed decisions about the use of a medicine, by providing a comprehensive summary of the scientific evidence available. The document is also intended to provide patients with clear and understandable information about the medicine they are taking, including its benefits and risks.